ALFA FinderBSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹888.00
- Market cap
- ₹5,318 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 613.5×Sector 43.8×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Other Announcement
Orchid Pharma's QIP monitoring report for the quarter ended September 2026 shows no deviation from objects. It flags revised fund allocation and delayed Jammu facility commercial operations.
Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Other board meeting date announcements
All →Fine Line Circuits Board Meeting Date
Fine Line Circuits will hold a board meeting on 14 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 16 November 2026.
Trans India House Impex Board Meeting Date
Trans India House Impex postponed its board meeting from 13 to 16 November 2026. The meeting will consider September 2026 quarter and half-year results.
SML Mahindra Board Meeting Date
SML Mahindra rescheduled its board meeting to 16 November 2026 to consider rights issue terms. No financial value is stated in the filing.
Classic Filaments Board Meeting Date
Classic Filaments adjourned its board meeting from November 13 to November 14, 2026, to clarify its financial results. The trading window stays closed until 48 hours after the results are declared.
Vani Commercials Board Meeting Date
Vani Commercials has given notice of a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The filing also notes the trading window closure.
Esaar (India) Board Meeting Date
Esaar India adjourned its 13 November 2026 board meeting to 14 November 2026. Trading window stays closed until 48 hours after the results announcement.